State of Alaska Department of Revenue reduced its stake in shares of Encompass Health Co. (NYSE:EHC – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,691 shares of the company’s stock after selling 175 shares during the quarter. State of Alaska Department of Revenue’s holdings in Encompass Health were worth $1,171,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB increased its position in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares during the period. UMB Bank n.a. boosted its holdings in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares in the last quarter. V Square Quantitative Management LLC boosted its holdings in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares in the last quarter. Avior Wealth Management LLC bought a new stake in shares of Encompass Health during the 3rd quarter valued at $40,000. Finally, Tompkins Financial Corp bought a new stake in shares of Encompass Health during the 4th quarter valued at $46,000. 97.25% of the stock is owned by hedge funds and other institutional investors.
Encompass Health Price Performance
EHC opened at $98.04 on Thursday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The stock has a market capitalization of $9.88 billion, a P/E ratio of 21.98, a P/E/G ratio of 1.18 and a beta of 0.90. The company’s 50-day simple moving average is $96.06 and its two-hundred day simple moving average is $95.43. Encompass Health Co. has a 52-week low of $72.53 and a 52-week high of $104.55.
Analyst Ratings Changes
A number of analysts have recently commented on the stock. William Blair restated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Barclays boosted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. StockNews.com cut shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Friday, February 7th. Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a research note on Tuesday. Finally, Truist Financial reiterated a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. One research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Encompass Health has a consensus rating of “Buy” and an average target price of $107.67.
Check Out Our Latest Research Report on Encompass Health
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Read More
- Five stocks we like better than Encompass Health
- 3 Warren Buffett Stocks to Buy Now
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- What Does a Stock Split Mean?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.